EDENRED EO 2/ FR0010908533 /
30.05.2024 15:21:06 | Изменение -1.850 | Объем сделки | Бид22:00:02 | Предложение22:00:02 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
42.420EUR | -4.18% | 0 Оборот: 0.000 |
-Величина цены спроса: - | -Величина цены предложения: - | 10.46 млрдEUR | 2.62% | 39.25 |
GlobeNewswire
22:51
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...
GlobeNewswire
22:50
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
GlobeNewswire
22:47
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
GlobeNewswire
22:38
Culinary Tours partners with Tennis Channel to create French-inspired recipes for French Open
GlobeNewswire
22:30
American Lithium Announces Financial and Operating Highlights for Year and Quarter Ended February 29...
GlobeNewswire
22:30
Ispire Technology Inc. to Present at the KCSA Cannabis Virtual Investor Conference June 5th
GlobeNewswire
22:30
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
22:30
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncolo...
GlobeNewswire
22:30
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
GlobeNewswire
22:25
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница